New Jersey Patent of the Month – February 2024
Covellus, LLC, a trailblazer in the realm of medical device innovation, has been granted a patent for their design for a catheter adaptor. This revolutionary adapter is not just an accessory; it’s a game-changer in the field of medical procedures, offering a modular approach to catheter design that promises enhanced flexibility and customization.
The first peripheral vascular PTA balloon intervention was invented more than 40 years ago and ever since, unitary catheter assemblies have been used to advance interventional therapeutic techniques throughout the body. Covellus takes a new approach to catheters, working to expand functionality and purpose. With conventionally designed catheters, there is no means to configure the device for specific procedural situations. This means that a medical facility must stock dozens or hundreds of units to be a viable product. By creating a modular catheter, Covellus is working to unlock ideas to advance the state of care in many critical areas, ushering in a new era of agile Modular Catheter Systems.
At its core, the newly patented adapter boasts a sophisticated design, featuring an attachment mechanism meticulously engineered to couple seamlessly with a medical device catheter. The slender element extending from the distal portion of the adapter along the outer surface of the catheter is a stroke of genius, adding a dynamic dimension to the conventional catheter structure.
The adapter’s architecture incorporates an elongated element, enhancing its versatility. This element, intricately woven into the attachment mechanism, provides both stability and adaptability. The attachment mechanism itself is a marvel, with a two-part design ensuring a secure connection with the catheter, yet allowing for easy detachment when needed.
Covellus has taken the concept of adaptability a step further. The adapter is not confined within the catheter but extends beyond, showcasing a design that can engage the lumen of the catheter’s distal end. This feature opens up possibilities for modifying or augmenting the medical device’s configuration, offering a tailored approach to various medical procedures.
The modular medical device catheter system introduced by Covellus allows for dynamic coupling, expanding the capabilities of medical devices. The adapter’s slender element plays a key role, extending along the parent module’s outer surface, creating a cohesive and functional unit.
Covellus’s adapter is not just a standalone invention; it’s part of a continuum. The patent details reveal a meticulous continuation of ideas, building upon previous innovations and incorporating them into a comprehensive modular catheter system. This approach showcases Covellus’s commitment to pushing the boundaries of what’s possible in the realm of medical technology.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
